ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Hot Features

Registration Strip Icon for alerts Registrieren Sie sich für Echtzeit-Benachrichtigungen, benutzerdefinierte Portfolios und Marktbewegungen.
Northwest Biotherapeutics Inc (QB)

Northwest Biotherapeutics Inc (QB) (NWBO)

0,274
0,002
(0,74%)
Geschlossen 21 November 10:00PM

Ihr Hub für Echtzeit-Streaming-Zitate, Ideen und Live-Diskussionen

Wichtige Statistiken und Details

Current Price
0,274
Gebot
0,274
Fragen
0,28
Volumen
1.704.044
0,271 Tagesbereich 0,2899
0,242 52-Wochen-Bereich 0,898
Marktkapitalisierung
Handelsende
0,272
Handelsbeginn
0,2899
Letzte Trade
5000
@
0.274
Letzter Handelszeitpunkt
Finanzvolumen
US$ 470.710
VWAP
0,276231
Durchschnittliches Volumen (3 Mio.)
2.145.595
Ausgegebene Aktien
1.297.445.623
Dividendenrendite
-
Kurs-Gewinn-Verhältnis
-3,43
Gewinn pro Aktie (EPS)
-0,05
Erlöse
1,93M
Nettogewinn
-64,37M

Über Northwest Biotherapeutics Inc (QB)

Northwest Biotherapeutics, Inc. is a development stage biotechnology company focused on discovering, developing and commercializing immunotherapy products that generate and enhance immune system responses to treat cancer. The Company operates in the United States, the UK, Germany and Canada and is i... Northwest Biotherapeutics, Inc. is a development stage biotechnology company focused on discovering, developing and commercializing immunotherapy products that generate and enhance immune system responses to treat cancer. The Company operates in the United States, the UK, Germany and Canada and is incorporated in Delaware, USA. Mehr anzeigen

Sektor
Pharmaceutical Preparations
Branche
Pharmaceutical Preparations
Hauptsitz
Wilmington, Delaware, USA
Gegründet
-
Northwest Biotherapeutics Inc (QB) is listed in the Pharmaceutical Preparations sector of the OTCMarkets with ticker NWBO. The last closing price for Northwest Biotherapeutics (QB) was US$0,27. Over the last year, Northwest Biotherapeutics (QB) shares have traded in a share price range of US$ 0,242 to US$ 0,898.

Northwest Biotherapeutics (QB) currently has 1.297.445.623 shares in issue. The market capitalisation of Northwest Biotherapeutics (QB) is US$352,91 million. Northwest Biotherapeutics (QB) has a price to earnings ratio (PE ratio) of -3.43.

NWBO Neueste Nachrichten

Zeitraum †ÄnderungÄnderung %HandelsbeginnHochNiedrigDurchsch. VolumenVWAP
1-0.043-13.56466876970.3170.3170.2717848030.28238347CS
4-0.006-2.142857142860.280.32990.24220545610.27975507CS
12-0.071-20.57971014490.3450.3450.24221455950.2991468CS
26-0.192-41.20171673820.4660.50.24221151810.34747128CS
52-0.5492-66.71525753160.82320.8980.24218937290.45285801CS
156-0.621-69.38547486030.8952.050.24221636550.6928468CS
2600.057126.32549562010.21692.540.00524018440.83618413CS
  • Volumen
  • % Tops
  • % Flops
SymbolPreisVol.
EGRNFChina Evergrande Group (CE)
US$ 0,0102
(1.019.900,00%)
900
WRCDFWirecard AG (CE)
US$ 0,01
(999.900,00%)
350
CCTLCoin Citadel (PK)
US$ 0,0002
(19.900,00%)
1,28M
RDVARDVA Inc (CE)
US$ 0,0002
(19.900,00%)
10k
AGRDFMinnova Corporation (PK)
US$ 0,0101
(10.000,00%)
10k
ISUNQiSun Inc (CE)
US$ 0,000001
(-99,86%)
12,5k
YAYOYayYo Inc (CE)
US$ 0,000001
(-99,80%)
44,61k
GBCHFMetaverse Capital Corporation (CE)
US$ 0,000001
(-99,00%)
200
BTTXBetter Therapeutics Inc (CE)
US$ 0,000001
(-99,00%)
60,2k
NTRRNeutra Corporation (CE)
US$ 0,000001
(-99,00%)
40k
THBDThird Bench Inc (PK)
US$ 0,0001
(0,00%)
183,32M
RDARRaadr Inc (PK)
US$ 0,0006
(-25,00%)
131,72M
BDPTBioadaptives Inc (PK)
US$ 0,0001
(-50,00%)
121,82M
GRLFGreen Leaf Innovations Inc (PK)
US$ 0,0001
(0,00%)
111,8M
AITXArtificial Intelligence Technology Solutions Inc (PK)
US$ 0,003
(-14,29%)
97,54M
Keine Diskussionen Gefunden.
Neuen Thread Erstellen

Kürzlich von Ihnen besucht

Delayed Upgrade Clock